# Preformed Line Products Company (PLPC) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Industrials / Electrical Equipment. Price $398.45, market value $1.9 billion.

## Valuation
- **P/E (trailing): 44.8×** (5-yr avg 14.5×, 3-yr avg 18.7×). Preformed Line Products Company trades at 44.8× trailing earnings, well above its own five-year average of 14.5×: investors are paying up relative to the company's past. The Industrials median in the September 2026 study was 25.7×.
- **Price / sales: 2.6×**. Each dollar of revenue is priced at 2.6×.
- **Price / book: 3.9×**. The shares trade at 3.9× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 21.9×**. Enterprise value is 21.9× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.
- **Free-cash-flow yield: 1.8%** (5-yr avg 4.8%). Free cash flow equals 1.8% of the market value, below its five-year average of 4.8%, so the shares are pricier on cash than usual.
- **Earnings yield: 2.2%**. The inverse of the P/E: 2.2% of the price is earned each year.

## Profitability
- **Gross margin: 31.4%**. Preformed Line Products Company keeps 31.4% of revenue after the direct cost of what it sells.
- **Operating margin: 9.0%**. 9.0% of revenue is left after running the business.
- **Net margin: 5.3%**. 5.3% of each dollar of sales reaches the bottom line.
- **Return on equity: 7.4%**. 7.4% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 10.2%**. Return on all capital, debt included, is 10.2%.
- **Return on assets: 6.6%**. Each dollar of assets produces 6.6% of profit.

## Growth
- **Revenue growth (1 yr): 12.7%** (3-yr 1.7%/yr, 5-yr 7.5%/yr). Revenue grew 12.7% over the last year, against 7.5% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): -4.8%** (3-yr -13.1%/yr, 5-yr 3.6%/yr). Earnings per share fell 4.8%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 0.08**. Debt is 0.08 times equity: a conservative balance sheet.
- **Current ratio: 3.17** (quick 3.17). Current assets cover the next year's liabilities 3.17 times.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 0.21%** ($0.83 per share, trailing). Preformed Line Products Company yields 0.21%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 12%** (12% of free cash flow). 12% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 3**. 3 straight years of increases.
- **Dividend growth (5 yr): 0.0%/yr** (1-yr 0.0%). The dividend has not grown over five years.

## Price and momentum
- **Total return (1 yr): 108.9%** (YTD 93.2%, 3-mo 9.8%). The shares are up 108.9% over twelve months including dividends.
- **From 52-week high: -21.1%** (116.5% above the low). Trading 21% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 47**. An RSI of 47 is neutral.
- **Beta (1 yr): 2.35** (volatility 64%). Beta of 2.35 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=PLPC · Page: https://foliofundamentals.com/stocks/plpc

Not investment advice.